Working GroupUCSF, United States
3: Oncologic Outcomes with De-Escalation of Axillary Surgery after Neoadjuvant Chemotherapy for Breast Cancer: Results from >1,500 patients on the I-SPY2 Clinical Trial
Friday, March 22, 20241:26pm – 1:38pm ET